The risk score model yielded almost 100% prediction accuracy of 13-year dementia risk.
Single dose of zilebesiran linked to reduction in systolic BP
Feb 20, 2024
A significant reduction was seen in systolic blood pressure with zilebesiran 150, 300 or 600 mg once in six months and 300 mg once every three months.
Opioid Rx down for chronic noncancer pain, cancer pain in U.S. adults
Aug 15, 2022
Declines in opioid prescribing are outpacing increases in the receipt of nonopioid therapies.
Diet to induce weight loss can reduce blood pressure in Type 2 diabetes
Jun 04, 2021
69 of 78 participants on treatment for hypertension stopped all or some antihypertensive and diuretic meds.
Links between genetic risk, glaucoma prevalence examined
Jul 23, 2021
Polygenic variants are associated with comparable risk for developing open-angle glaucoma as that associated with the most common single-gene pathogenic variant, according to a study published online July...
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In a randomized, double-blind trial, no difference was seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo.
Small CV impact seen when replacing salt with low-sodium salt substitute
Aug 24, 2022
The small effects of LSSS versus regular salt on cardiovascular health in adults may be important when implemented at the population level
Watchdog group says US food recalls rose again last year
Apr 25, 2024
US recalls of foods for salmonella, foreign objects or undeclared allergens are rampant nowadays and the highest they’ve been since 2020, a watchdog group warns.
Gains in heart health only experienced by higher-income populations
Apr 19, 2024
The 10-year risk for cardiovascular disease remained stagnant at >8% for US adults with the lowest incomes in 1988 to 2018.
IV Ketamine not a ‘silver bullet’ for depression, but does help some
Feb 09, 2024
One-fourth with treatment-resistant depression show a response at six weeks.